Female pseudohermaphroditism and inefficient peak bone mass in an untreated subject affected by 21-hydroxylase congenital adrenal hyperplasia.
Here we describe a subject with congenital adrenal hyperplasia due to 21-hydroxylase deficiency (21-CAH), in its classical virilizing form, who presented at birth ambiguous genitalia and subsequently was assigned by the parents as male. At the age of 8 years, he underwent a two-step surgical correction of hypospadia and at 22 years old, uterus and ovaries were removed and a bilateral testicular prothesis was surgically placed in scrotum. He refused any chronic glucocorticoid therapy, that was given only acutely to prevent adrenal crises during stress, trauma surgery or severe illness. The patient is now 38 years old, he is genotypically female but phenotypically male, with high endogenous levels of androgen, all of adrenal origin, and with an apparent male sexual life. He had severe osteopenia, probably due to the lack of estrogen/androgen-induced increase in bone mineral density, although periferal estrogen conversion was normal. His skeletal mass, in fact, normally acquired during adolescence and early adult life, could in this case be inefficient, for the precocious pseudopuberty, that caused an inefficient peak bone mass in adolescence period.
Valentino
R
R
CNR, Experimental Endocrinology and Oncology Center (CEOS), Department of Cellular and Molecular Biology and Pathology, Medical School, University Federico II, Naples, Italy.
Savastano
S
S
Tommaselli
A P
AP
Dorato
M
M
Scarpitta
M T
MT
Calvanese
E
E
Del Puente
A
A
Lombardi
G
G
D000312:Adrenal Hyperplasia, Congenital / Q000150:complications*; D000328:Adult; D000728:Androgens / Q000097:blood / Q000652:urine; D015519:Bone Density; D001851:Bone Diseases, Metabolic / Q000188:drug therapy / Q000209:etiology*; D002118:Calcium / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use; D012734:Disorders of Sex Development / Q000209:etiology*; D005260:Female; D006801:Humans; D010641:Phenotype; D013131:Spine; D014807:Vitamin D / Q000627:therapeutic use
D000728:Androgens; D004164:Diphosphonates; D014807:Vitamin D; D002118:Calcium